logo
  1. Home
  2. Stocks
  3. Wockhardt

Wockhardt Share Price

Small Cap | Pharmaceuticals and health care | NSE: WOCKPHARMA | BSE: 532300

₹1,347.80 image-70.90 (-5.00 %)

Last Updated: 04 Apr 2025 03:59 PM

Technicalsimage BULLISHimage

Overview

Open (₹) 1,424.70

High (₹) 1,427.95

Low (₹) 1,347.80

Prev. Close (₹) 1,418.70

Volume 5,90,103

VWAP (₹) 1,127.55

ROCE (%) -2.07

Industry P/E 46.49

TTM P/E -114.71

P/B Ratio 5.67

Market Cap (₹) Cr.21,899.80

Dividend Yield (%)--

EPS (₹) -32.05

ROE-13.48%

Sales Growth (%) 5.55

Profit Growth (%)-23.99

Day Range

1,427.951,427.95

L
H

52 Week Range

489.201,678.60

L
H

Historical Returns

Returns (6M)

43.38 %

Returns (1Y)

130.51 %

Returns (3Y)

360.71 %

Returns (5Y)

621.67 %

Returns (6M)

43.38 %

Returns (1Y)

130.51 %

Returns (3Y)

360.71 %

Returns (5Y)

621.67 %

SWOT Analysis

  • Efficient in managing Assets to generate Profits - ROA improved since last year
  • Growth in Net Profit Margin (QoQ)
  • Growth in Annual Net Profit with increasing Profit Margin (YoY)
  • Strong short-term momentum: Price above short-term moving averages (EMA_10)
  • Strong long-term momentum: Price above long-term moving averages (EMA_200)
  • Price above the pivot point indicates bullish sentiment.

Technicals
info_icon

Technical Rating

Trendimage  BULLISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 35.02

MFI 18.57

ATR 81.38

Commodity Channel Index -153.49

ROC125 15.48

ROC21 -10.29

Williams %R -90.89

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current1,191.451,227.401,268.101,150.751,114.801,074.101,038.15
Week Ago1,375.701,434.851,464.751,345.801,286.651,256.751,197.60
Month Ago1,336.341,396.671,482.291,250.721,190.391,104.771,044.44

EMA & SMA
info_icon

1347.80

Current Price

EMA & SMApin

Bullish Moving Averages

11

Bearish Moving Averages

9

5 Day 1257.34

9 Day 1318.23

10 Day 1318.93

12 Day 1355.72

14 Day 1375.91

20 Day 1443.08

26 Day 1404.50

50 Day 1416.05

100 Day 1309.51

200 Day 1063.89

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
GRAVITON RESEARCH CAPITAL LLPbulkSell01 Jan, 2024₹456.728,44,583NSE
GRAVITON RESEARCH CAPITAL LLPbulkBuy01 Jan, 2024₹456.768,44,583NSE
GRAVITON RESEARCH CAPITAL LLPbulkSell12 Dec, 2023₹397.269,79,549NSE
GRAVITON RESEARCH CAPITAL LLPbulkBuy12 Dec, 2023₹397.139,79,549NSE
GRAVITON RESEARCH CAPITAL LLPbulkSell11 Dec, 2023₹372.839,16,319NSE
GRAVITON RESEARCH CAPITAL LLPbulkBuy11 Dec, 2023₹373.229,16,319NSE
GRAVITON RESEARCH CAPITAL LLPbulkSell17 Nov, 2023₹325.1711,48,101NSE
GRAVITON RESEARCH CAPITAL LLPbulkBuy17 Nov, 2023₹324.8111,48,101NSE
YUGA STOCKS AND COMMODITIES PRIVATE LIMITED .bulkSell16 Nov, 2023₹318.1311,64,955NSE
QE SECURITIES LLPbulkSell16 Nov, 2023₹313.7510,66,935NSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
27 Dec, 2024Muayyad KhorakiwalaAcquisition₹1,800NSE
11 Mar, 2022Themisto Trustee Company Private LimitedPledge₹313.1517,40,000NSE
01 Mar, 2022Themisto Trustee Company Private LimitedPledge₹340.3352,20,000NSE
28 Dec, 2021Themisto Trustee Company Private LimitedPledge₹393.9519,00,000NSE
02 Dec, 2021Themisto Trustee Company Private LimitedPledge₹435.554,00,000NSE
26 Oct, 2021Themisto Trustee Company Private LimitedPledge₹462.3013,50,000NSE
11 Oct, 2021Themisto Trustee Company Private LimitedRevoke₹480.3098,000NSE
03 Sept, 2021Themisto Trustee Company Private LimitedPledge₹420.201,90,000NSE
03 Sept, 2021Themisto Trustee Company Private LimitedPledge₹403.0812,40,000NSE
01 Sept, 2021Ananke Trustee Company Private LimitedDisposal₹399.113,00,000NSE

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
06 Jan, 2022Rights issue of equity shares of Rs. 5/- each in the ratio of 3:10 @ premium of Rs. 220/-.08 Mar, 202209 Mar, 2022

Announcements

DateSourceDetail
01 Apr, 2025NSE IndiaWockhardt Limited has informed the Exchange regarding a press release dated April 01, 2025, titled Paediatric US Cancer Patient with Recalcitrant Blood and Liver Infection Successfully Treated with Zaynich (Zidebactam/Cefepime, WCK 5222)""
01 Apr, 2025BSE IndiaPursuant to Regulation 30 of SEBI Listing Regulations, please find enclosed Press Release - \Paediatric US Cancer Patient with Recalcitrant Blood and Liver Infection Successfully Treated with ZaynichTM (Zidebactam/Cefepime, WCK 5222)
27 Mar, 2025NSE IndiaWockhardt Limited has informed the Exchange about Closure of Trading Window
27 Mar, 2025NSE IndiaWockhardt Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
14 Feb, 2025BSE IndiaWe wish to inform you that the Share allotment Committee of the Board of Directors of the Company has allotted 13,250 equity shares of face value Rs. 5/- each on 14th February, 2025
14 Feb, 2025BSE IndiaWe wish to inform you that the Share allotment Committee of the Board of Directors of the Company has allotted 13,250 equity shares of face value Rs. 5/- each on 14th February, 2025
14 Feb, 2025NSE IndiaWockhardt Limited has informed the Exchange regarding Allotment of Securities
14 Feb, 2025NSE IndiaWockhardt Limited has informed the Exchange regarding allotment of 13,250 equity shares of face value of Rs.5/- each on 14th February, 2025, pursuant to exercise of stock options under Employee Stock Options Scheme - 2011 of the Company
07 Feb, 2025BSE IndiaWe are submitting herewith the Integrated Filing (Financial) for the quarter and nine months ended 31st December 2024.
07 Feb, 2025NSE IndiaPursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated 31st December, 2024, read with BSE Circular No. 20250102-4 and NSE Circular No. NSE/CML/2025/02 dated 2nd January, 2025, we are submitting herewith the Integrated Filing (Financial) for the quarter and nine-months ended 31st December, 2024

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results--04 Feb, 202507 Feb, 2025
Quarterly Results--09 Nov, 202413 Nov, 2024
Quarterly Results--06 Aug, 202409 Aug, 2024
Audited Results--22 May, 202428 May, 2024
OthersInter alia, to consider and determine the issue price of Equity Shares to be issued pursuant to the Issue, including any discount, not more than 5%, on the floor price.22 Mar, 202426 Mar, 2024
Quarterly Results--06 Feb, 202414 Feb, 2024
Quarterly Results--07 Nov, 202314 Nov, 2023
Quarterly Results--07 Aug, 202314 Aug, 2023
Audited Results & OthersTo consider : Raising of funds by various method as may be permitted under applicable law, subject to consent of shareholder at the ensuing Annual General Meeting and such approvals.22 May, 202326 May, 2023
Quarterly Results--06 Feb, 202313 Feb, 2023

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Dec, 2023Dec, 2022Dec, 2021Dec, 2020
Promoter Group49.09%54.93%60.36%67.13%72.12%
Foreign Institutions +6.54%4.18%2.87%2.94%4.06%
Domestic Institutions +9.82%0.33%0.22%0.1%0.06%
Government0.02%0%0%0%0%
Public34.53%40.56%36.55%29.83%23.76%
Others0%0%0%0%0%

About Wockhardt

Wockhardt is a Public Limited Listed company incorporated on 08/07/1999 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1999PLC120720 and registration number is 120720. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1154.00 Cr. and Equity Capital is Rs. 77.00 Cr. for the Year ended 31/03/2024. Read More

Parent Organisation

Wockhardt Group

Founded

1999

Managing Director

Dr. Murtaza Khorakiwala

NSE Symbol

WOCKPHARMA

Wockhardt Management

NameDesignation
Dr. Habil KhorakiwalaFounder Chairman
Dr. Murtaza KhorakiwalaManaging Director
Dr. Huzaifa KhorakiwalaExecutive Director
Ms. Zahabiya KhorakiwalaNon Executive Director
Mrs. Tasneem MehtaIndependent Director
Mr. Vinesh Kumar JairathIndependent Director
Mr. Akhilesh GuptaIndependent Director
Ms. Amelia FernandesIndependent Director
Mr. Ahmad JavedIndependent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,10,130.32₹1,709.35 image
₹1,770.00(-3.43%)		₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,45,552.44₹5,482.85 image
₹5,763.00(-4.86%)		₹3,613.550 - ₹6,448.750
Cipla₹1,14,298.01₹1,415.25 image
₹1,495.70(-5.38%)		₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,11,230.09₹3,286.50 image
₹3,247.70(1.19%)		₹2,508.650 - ₹3,589.950
Mankind Pharma₹1,01,131.25₹2,451.20 image
₹2,427.70(0.97%)		₹1,910.100 - ₹3,050.000

FAQs on Wockhardt

What is the share price of Wockhardt?

The share price of Wockhardt on 04 Apr, 2025 is ₹ 1,347.80.

What is 52W high and 52W low share price of Wockhardt?

The highest and lowest 52W share prices of Wockhardt are ₹ 1678.600 and ₹ 489.200

What is the market cap of Wockhardt?

The market capitalization of Wockhardt as of 04 Apr, 2025 is ₹ 21,899.80 Crores

What is the P/E ratio of Wockhardt?

The current P/E ratio of Wockhardt as of 04 Apr, 2025 is 46.49

What is the PB ratio of Wockhardt?

The PB ratio of Wockhardt as of 04 Apr, 2025 is 5.67

Top Gainers

GLOBUSCON

Globus Power Generation

₹18.07image

₹15.14 (0.19%)

SHANTIDENM

Shanti Spintex

₹66.60image

₹57.80 (0.15%)

DEL

Dhanashree Electronics

₹88.74image

₹73.95 (0.20%)

PARSHVA

Parshva Enterprises

₹197.50image

₹167.35 (0.18%)

Top Losers

GOLDIAM

Goldiam International

₹307.35image

₹368.55 (-0.17%)

EVERFIN

Everlon Financials

₹108.20image

₹127.00 (-0.15%)

KBCGLOBAL

KBC Global

₹0.54image

₹1.03 (-0.48%)

GRWRHITECH

Garware Hi-Tech Films

₹2,705.55image

₹3,206.90 (-0.16%)

Market Indices

Sensex

₹75,364.69image

₹76,295.36 (-0.01%)

Source : Dion Global Solutions Limited